SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-041556
Filing Date
2020-08-27
Accepted
2020-08-27 16:49:02
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-10q_20200630.htm 10-Q 2708116
2 EX-31.1 alxo-ex311_11.htm EX-31.1 18056
3 EX-31.2 alxo-ex312_10.htm EX-31.2 18182
4 EX-32.1 alxo-ex321_8.htm EX-32.1 9458
5 EX-32.2 alxo-ex322_9.htm EX-32.2 9431
  Complete submission text file 0001564590-20-041556.txt   7989029

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxo-20200630.xml EX-101.INS 1471404
7 XBRL TAXONOMY EXTENSION SCHEMA alxo-20200630.xsd EX-101.SCH 56118
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxo-20200630_cal.xml EX-101.CAL 47151
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20200630_def.xml EX-101.DEF 230272
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20200630_lab.xml EX-101.LAB 424113
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20200630_pre.xml EX-101.PRE 350161
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 201143529
SIC: 2834 Pharmaceutical Preparations